Conducts scientific exchange in the field with prioritized stakeholders, including Key Opinion Leaders (KOLs), Centers of Excellence (COEs), HCPs, patient advocacy groups, and societies in support of Medical Affair's strategies including: Supports strategies as directed by medical plans and establish a respected company presence in the neuroscience medical community; Establishes, cultivates, and maintains scientific relationships with stakeholders while developing a strong understanding of regional healthcare systems and clinical practices. Collaborating closely with the Medical Affairs leadership and various members of the Commercial team, MSL engages in scientific exchanges and enters into strategic discussions as they relate to medical/clinical, health economics and outcomes research (HEOR) data with HCPs including, but is not limited to: individual physicians and clinicians, researchers, managed markets, medical and pharmacy directors, hospital decision-makers, formulary committees, consultant pharmacists, state Medicaid decisionmakers, and others.